AVP BioPharma Consult ApS — Credit Rating and Financial Key Figures
CVR number: 37770426
Teknikerbyen 5, Søllerød 2830 Virum
avp@avp-biopharma.com
tel: 22663147
www.avp-biopharma.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 106.64 | 1 200.70 | 1 125.47 | 1 008.64 | 1 169.18 |
| Employee benefit expenses | - 856.83 | - 860.58 | - 931.83 | - 863.65 | - 856.84 |
| Total depreciation | -6.13 | -6.12 | -5.28 | ||
| EBIT | 243.68 | 334.01 | 193.64 | 139.71 | 312.34 |
| Other financial income | 1.02 | 1.61 | 0.77 | 0.64 | |
| Other financial expenses | -1.41 | -0.64 | -2.85 | -2.53 | -5.76 |
| Pre-tax profit | 243.29 | 334.97 | 190.79 | 137.95 | 307.22 |
| Income taxes | -53.52 | -74.25 | -42.39 | -31.75 | -69.43 |
| Net earnings | 189.76 | 260.72 | 148.39 | 106.20 | 237.79 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 11.39 | 5.28 | 5.28 | ||
| Tangible assets total | 11.39 | 5.28 | 5.28 | ||
| Other receivables | 10.20 | ||||
| Investments total | 10.20 | ||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 96.00 | 144.42 | 149.68 | 79.62 | 148.00 |
| Current amounts owed by group member comp. | 33.10 | 107.30 | 33.23 | 28.97 | 98.32 |
| Prepayments and accrued income | 3.40 | ||||
| Current other receivables | 0.10 | 33.90 | 8.81 | 10.78 | 12.94 |
| Current deferred tax assets | 22.63 | ||||
| Short term receivables total | 155.23 | 285.62 | 191.72 | 119.36 | 259.25 |
| Cash and bank deposits | 301.70 | 225.54 | 301.49 | 268.03 | 245.19 |
| Cash and cash equivalents | 301.70 | 225.54 | 301.49 | 268.03 | 245.19 |
| Balance sheet total (assets) | 478.52 | 516.44 | 498.49 | 387.39 | 504.45 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Share premium account | 5.00 | ||||
| Shares repurchased | 210.00 | 200.00 | 175.00 | 140.00 | 250.00 |
| Retained earnings | - 159.79 | - 165.02 | -79.30 | -70.91 | - 214.71 |
| Profit of the financial year | 189.76 | 260.72 | 148.39 | 106.20 | 237.79 |
| Shareholders equity total | 294.97 | 345.70 | 294.09 | 225.29 | 323.08 |
| Provisions | 0.98 | 1.16 | 1.16 | ||
| Non-current liabilities total | |||||
| Current loans from credit institutions | 1.69 | 1.69 | 9.29 | ||
| Current trade creditors | 11.19 | 17.00 | 2.66 | 1.12 | 1.12 |
| Current owed to participating | 1.57 | 2.18 | 0.79 | ||
| Short-term deferred tax liabilities | 44.26 | 35.45 | 75.19 | ||
| Other non-interest bearing current liabilities | 169.68 | 150.89 | 154.75 | 123.35 | 94.98 |
| Current liabilities total | 182.56 | 169.59 | 203.24 | 162.10 | 181.37 |
| Balance sheet total (liabilities) | 478.52 | 516.44 | 498.49 | 387.39 | 504.45 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.